Erawat Pharma Limited - healthcare in Indore, Madhya Pradesh, India. FY 2026 financials and compliance.
CIN U02423MP1993PLC007538 Incorporated 01 March 1993 ROC Gwalior HQ Indore, Madhya Pradesh, India
Active Public Limited Company healthcare
Data last updated
Revenue · FY 2025
₹78.37 Cr
▲ 14.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹6.95 Cr
Registered with MCA
Paid-up capital
₹6.75 Cr
Issued & subscribed
Open charges
₹50 Cr
Satisfied ₹29.78 Cr
Company age
33 yrs
Est. 1993
Employees · EPFO
175
Latest available

About Erawat Pharma Limited

Data last updated: 17 December 2025

Erawat Pharma Limited is a public limited company based in Indore, Madhya Pradesh, India. It specialises in medical consumables and supplies, a part of the broader healthcare sector. Incorporated on 01 March 1993, the company has been in operation for over 33 years.

Registered with ROC Gwalior under CIN U02423MP1993PLC007538.

Capital: an authorised share capital of ₹6.95 Cr and a paid-up capital of ₹6.75 Cr. Formerly known as Erawat Pharma Private Limited. It is led by directors including Amit Jain and Vasant Raj Solanki.

Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: 12C F A Scheme No. 94 Ring Road, Indore, Madhya Pradesh, India – 452010.

As per the financials filed for FY 2025, the company reported a revenue of ₹78.37 Cr, a growth of 14% compared to the previous year.

The company has a workforce of approximately 175 employees as per the latest available data.

The company is associated with 2 brands - Erawat Group, Erawat. As per MCA filings, the company has open charges of ₹50 Cr and satisfied charges of ₹29.78 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website erawat.com.

Company Details of Erawat Pharma Limited
CIN U02423MP1993PLC007538
Registration Number 007538
Incorporation Date 01 March 1993
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
  • Registered Address
    12C F A Scheme No. 94 Ring Road, Indore, Madhya Pradesh, India – 452010
  • Industry
    Healthcare, Medical Consumables & Supplies
Company report
Erawat Pharma Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Erawat Pharma Limited report

Financials, compliance, directors, charges, ownership and filings for Erawat Pharma Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Erawat Pharma Limited

Erawat Pharma Limited operates two associated brands: Erawat Group and Erawat. These brands represent Erawat Pharma Limited's diversified market presence and brand portfolio.

Brand Description Website
Manufactures hard gelatin capsules and capsule manufacturing machines. erawatgroup.com
Manufacturing of empty hard capsules and HPMC capsules for pharmaceutical use in India. erawat.com

Competitors & Alternatives of Erawat Pharma Limited

Brands and companies operating in the same space as Erawat Pharma Limited include Jubilant Life Sciences, Akums, Nectar Lifesciences and 5 more.

Competitor Description Location Founded
Jubilant Life Sciences Jubilant Life Sciences Company offering a suite of R&D and manufacturing services for small molecules and generics Noida, India, India 1978
Akums Akums CDMO focusing on spectrum of dosage forms and therapeutic segments Delhi, India, India 2004
Nectar Lifesciences Nectar Lifesciences Cephalosporin APIs and generic formulations are manufactured. Chandigarh, India, India 1995
Windlas Windlas Biopharma regulatory affairs, quality control, and strategy services are provided. Gurugram, India, India 2001
Unither Unither Contract development and manufacturing organization for proprietary and generic drugs Paris, France, France 1993
Recipharm Recipharm Pharmaceutical development and manufacturing services are offered contractually. Jordbro, Sweden, Sweden 1995
CoreRx CoreRx CDMO with a focus on early phase drug product development Clearwater, United States, United States 2006
MedPharm MedPharm Topical and inhaled drug delivery formulations are developed and manufactured. Guildford, United Kingdom, United Kingdom 1998

Business Activity of Erawat Pharma Limited

Erawat Pharma Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Erawat Pharma Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Erawat Pharma Limited

Erawat Pharma Limited is audited by Mahesh Virendra & Co. for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
Mahesh Virendra & Co. Locked Locked Locked
Premium access

Complete auditor history for Erawat Pharma Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Erawat Pharma Limited

Erawat Pharma Limited is currently managed by 7 directors, with 8 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Amit Jain Whole-Time Director 01 Oct 2018 7 Years 10 Months Current
Vasant Raj Solanki Director 16 Aug 1994 31 Years 11 Months Current
Devindar Singh Sodhi Director 30 Apr 1997 29 Years 3 Months Current
Hemchandra Jain Managing Director 01 Mar 1993 33 Years 5 Months Current
Abhijeet Jain Whole-Time Director 01 Oct 2018 7 Years 10 Months Current
Abhishek Jain Whole-Time Director 11 Jul 2003 23 Years 1 Months Current
Showing 6 of 7 current directors. View all directors

Financials of Erawat Pharma Limited FY 2024 filings available

Erawat Pharma Limited reported revenue of ₹78.37 Cr (up 14.00% YoY) for FY 2025.

Revenue · FY 2025
₹78.37 Cr ▲ 14.00%
Premium access

Ten-year financial statements for Erawat Pharma Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Erawat Pharma Limited

Premium access

Shareholding and ownership data for Erawat Pharma Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Erawat Pharma Limited

Open charges
₹50 Cr
Satisfied charges
₹29.78 Cr
Breakdown by lending institutions
Others₹47.90 Cr
Sidbi₹2.10 Cr
Latest charge details
DateLenderAmountStatus
20 Nov 2024 Sidbi ₹81.76 Lakh Open
26 Feb 2024 Others ₹89.08 Lakh Open
22 Nov 2023 Sidbi ₹1.28 Cr Open
13 Apr 2023 Others ₹8.24 Cr Open
21 Oct 2022 Others ₹6 Cr Open

Total charge records: 25 View all charges

Employees and EPFO Compliance at Erawat Pharma Limited

Erawat Pharma Limited has a workforce of 175 employees as of Apr 05, 2024.

Employee count
175
Active EPFO establishments
1
Employee growth
4.17%
Premium access

Employee and EPFO history for Erawat Pharma Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Erawat Pharma Limited

Premium access

GST registrations and filing compliance for Erawat Pharma Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Erawat Pharma Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Erawat Pharma Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Erawat Pharma Limited

Premium access

MSME payment history for Erawat Pharma Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Erawat Pharma Limited

Premium access

Corporate group structure for Erawat Pharma Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Erawat Pharma Limited

Premium access

MCA filings and documents for Erawat Pharma Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Erawat Pharma Limited

Charges
20 Nov 2024
A charge with Sidbi amounted to Rs. 0.82 Cr with Charge ID 101006106 was registered on 20 Nov 2024.
Activity
30 Sep 2024
Erawat Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
09 Aug 2024
A charge with Others of Rs. 0.89 Cr registered on 26 Feb 2024 with Charge ID 100886118 was modified on 09 Aug 2024.
Charges
09 Aug 2024
A charge with Others of Rs. 6.00 Cr registered on 21 Oct 2022 with Charge ID 100628027 was modified on 09 Aug 2024.
Charges
09 Aug 2024
A charge with Others of Rs. 0.69 Cr registered on 21 Oct 2022 with Charge ID 100627269 was modified on 09 Aug 2024.
Charges
09 Aug 2024
A charge with Others of Rs. 0.43 Cr registered on 21 Oct 2022 with Charge ID 100627262 was modified on 09 Aug 2024.

Frequently Asked Questions about Erawat Pharma Limited

Erawat Pharma Limited is an active public limited company in the healthcare sector based in Indore, Madhya Pradesh, India. It was incorporated on 01 March 1993 (33+ years old) and is registered under CIN U02423MP1993PLC007538. The company has 175 employees.

Erawat Pharma Limited reported revenue of ₹78.37 Cr for FY 2025 (up 14.00% YoY).

The current directors of Erawat Pharma Limited are:

The primary industry of Erawat Pharma Limited is healthcare. The company specifically operates in medical consumables and supplies. The company is currently active in this sector.

Erawat Pharma Limited can be reached at the registered office: 12C F A Scheme No. 94 Ring Road, Indore, Madhya Pradesh, India – 452010, or through the website erawat.com.

The authorised capital is ₹6.95 Cr, and the paid-up capital is ₹6.75 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available